Search

Theragnostic Imaging

Theragnostic Imaging

News
People
Events
Publications
RNTreg
Contact

Tore Bach-Gansmo

Latest

18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan

© 2025 Me. This work is licensed under CC BY NC ND 4.0

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.